The effect of low-dose spironolactone on resistant hypertension

Journal of the American Society of Hypertension

Volumn 4, Issue 6, 2010, Pages 290-294

  Engbaek, Mette ^a   Hjerrild, Mette ^a   Hallas, Jesper ^a   Jacobsen, Ib A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aldosterone antagonism; Hypertension; Resistant hypertension; Spironolactone

Indexed keywords

ANTIHYPERTENSIVE AGENT; POTASSIUM; SPIRONOLACTONE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; COMORBIDITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GYNECOMASTIA; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPONATREMIA; IMPOTENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ERECTILE DYSFUNCTION; FEMALE; GLOMERULAR FILTRATION RATE; GYNECOMASTIA; HUMANS; HYPERKALEMIA; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES; SPIRONOLACTONE;

EID: 78649980871     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.10.001     Document Type: Article

References (15)

1. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
2. R.L. Wolf, M. Mendlowitz, J. Roboz, G.P. Styan, P. Kornfeld, and A. Weigl Treatment of hypertension with spironolactone. Double-blind study JAMA 198 1966 1143 1149
3. J. Quzan, C. Perault, A.M. Lincoff, E. Carre, and M. Mertes The role of spironolactone in the treatment of patients with refractory hypertension Am J Hypertens 15 2002 333 339
4. M.K. Nishizaka, M.A. Zaman, and D.A. Calhoun Efficacy of low-dose spironolactone in subjects with resistant hypertension Am J Hypertens 16 2003 925 930
5. Y. Sharabi, E. Adler, A. Shamis, N. Nussinovitch, A. Markovitz, and E. Grossman Effacacy and add-on aldosterone receptor blocker in uncontrolled hypertension Am J Hypertens 19 2006 750 755
6. N. Chapman, J. Dobson, S. Wilson, B. Dahlof, P.S. Sever, and H. Wedel Effect of spironolactone on blood pressure in subjects with resistant hypertension Hypertension 49 2007 839 845
7. D.A. Lane, S. Shah, and D.G. Beevers Low dose spironolactone in the management of resistant hypertension: a surveillance study J Hypertens 25 2007 891 894
8. F. De Souza, E. Muxfeldt, R. Fiszman, and G. Salles Efficacy of spironolactone therapy in patients with true resistant hypertension. Inter-American Society of Hypertension Hypertension 55 2010 147 152
9. D. Gaist, H.T. Sørensen, and J. Hallas The Danish prescription registers Dan Med Bull 44 1997 445 448
10. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
11. J. Staessen, P. Lijnen, R. Fagard, L.J. Verschueren, and A. Amery Rise in plasma concentration of aldosterone during long-term angiotensin II suppression J Endocrinol 91 1981 457 465
12. K.J. Schjoedt, S. Andersen, P. Rossing, L. Tarnow, and H.H. Parving Aldosterone escape during blockade of the rennin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate Diabetologia 47 2004 1936 1939
13. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
14. X. Jeunemaitre, G. Chatellier, C. Kreft-Jais, A. Charru, C. DeVries, and P.F. Plouin Efficacy and tolerance of spironolactone in essential hypertension Am J Cardiol 60 1987 820 825
15. J.M. Last, A dictionary of epidemiology 4th ed 2001 Oxford University Press New York